You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/69670
Title: 
Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY)
Author(s): 
Institution: 
  • Universidade de São Paulo (USP)
  • Universidade Federal de São Paulo (UNIFESP)
  • Universidade Estadual Paulista (UNESP)
  • Instituto Fleury
ISSN: 
0049-3848
Abstract: 
Introduction: Venous thrombosis (VT) and inflammation are two closely related entities. In the present investigation we assessed whether there is a relation between genetic modifiers of the inflammatory response and the risk of VT. Materials and methods: 420 consecutive and unrelated patients with an objective diagnosis of deep VT and 420 matched controls were investigated. The frequencies of the following gene polymorphisms were determined in all subjects: TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G. Results: Overall odds ratio (OR) for VT related to TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, A1 allele (4 bp repeat) of the IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G were respectively: 1.0 (CI95: 0.8-1.5), 1.3 (CI95: 1.0-1.7), 1.1 (CI95: 0.9-1.5), 1.6 (CI95: 1-2.5), 1.2 (CI95: 0.8-1.7) and 0.8 (CI95: 0.6-1.1). A possible interaction between polymorphisms was observed only for the co-inheritance of the mutant alleles of the LT-α+ 252 A/G and IL-10-1082 G/A polymorphisms (OR = 2; CI95: 1.1-3.8). The risk of VT conferred by factor V Leiden and FII G20210A was not substantially altered by co-inheritance with any of the cytokine gene polymorphisms. Conclusions: Cytokine gene polymorphisms here investigated did not significantly influence venous thrombotic risk. © 2006 Elsevier Ltd. All rights reserved.
Issue Date: 
21-May-2007
Citation: 
Thrombosis Research, v. 120, n. 2, p. 221-229, 2007.
Time Duration: 
221-229
Keywords: 
  • Coagulation
  • Cytokines
  • Inflammation
  • Polymorphisms
  • Thrombosis
  • Venous thromboembolism
  • blood clotting factor 11
  • blood clotting factor 5 Leiden
  • CD31 antigen
  • cytokine
  • interleukin 1 receptor blocking agent
  • interleukin 10
  • interleukin 6
  • lymphotoxin
  • tumor necrosis factor alpha
  • cardiovascular risk
  • deep vein thrombosis
  • genetic polymorphism
  • inflammation
  • major clinical study
  • medical research
  • Base Sequence
  • Case-Control Studies
  • DNA Primers
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-10
  • Interleukin-6
  • Lymphotoxin-alpha
  • Middle Aged
  • Odds Ratio
  • Polymorphism, Genetic
  • Tumor Necrosis Factor-alpha
  • Variation (Genetics)
  • Venous Thrombosis
Source: 
http://dx.doi.org/10.1016/j.thromres.2006.09.015
URI: 
Access Rights: 
Acesso restrito
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/69670
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.